Microglia activation states and cannabinoid system: Therapeutic implications

Pharmacology and Therapeutics

Volumn 166, Issue , 2016, Pages 40-55

  Mecha, M ^a   Carrillo Salinas, F J ^a   Feliu A ^a   Mestre, L ^a   Guaza, C ^a  

^a CSIC   (Spain)

Author keywords

Cannabinoids; Microglia; Neurodegeneration; Neuroinflammation; Phenotypes; Repair

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID;

ANGIOGENESIS; ARTICLE; CELL ACTIVATION; CELL REGENERATION; CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NONHUMAN; PARABIOSIS; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; TISSUE REPAIR; UPREGULATION; ALZHEIMER DISEASE; ANIMAL; DEGENERATIVE DISEASE; IMMUNOLOGY; INFLAMMATION; PARKINSON DISEASE;

ALZHEIMER DISEASE; ANIMALS; CANNABINOIDS; CENTRAL NERVOUS SYSTEM; ENDOCANNABINOIDS; HUMANS; INFLAMMATION; MICROGLIA; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PHENOTYPE; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID;

EID: 84979708962     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.06.011     Document Type: Article

References (268)

1. Aarum, J., Sandberg, K., Haeberlein, S.L., Persson, M.A.A., Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci U S A 100 (2003), 15983–15988.
2. Ajami, B., Bennett, J.L., Krieger, C., Tetzlaff, W., Rossi, F.M., Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10 (2007), 1538–1543.
3. Akiyama, H., McGeer, P.L., Brain microglia constitutively express beta-2 integins. J Neuroimmunol 30 (1990), 81–93.
4. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000), 383–421.
5. Alliot, F., Lecain, E., Grima, B., Pessac, B., Microglial progenitors with a high proliferative potential in the embryonic and adult mouse brain. Proc Natl Acad Sci U S A 88 (1991), 1541–1545.
6. Amor, S., Puentes, F., Baker, D., Van der Valk, P., Inflammation in neurodegenerative diseases. Immunology 129:2 (2010), 154–169.
7. Arévalo-Martín, A., García-Ovejero, D., Gómez, O., Rubio-Araiz, A., Navarro-Galve, B., Guaza, C., et al. CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. Br J Pharmacol 153 (2008), 216–225.
8. Arévalo-Martín, A., Vela, J.M., Molina-Holgado, E., Borrell, J., Guaza, C., Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J Neurosci 23 (2003), 2511–2516.
9. Austin, S.A., Floden, A.M., Murphy, E.J., Combs, C.K., Alpha-synuclein expression modulates microglial activation phenotype. J Neurosci 26 (2006), 10558–10563.
10. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Makriyannis, A., et al. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J 15 (2001), 300–302.
11. Bayewitch, M., Rhee, M.H., Avidor-Reiss, T., Breuer, A., Mechoulam, R., Vogel, Z., (−)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J Biol Chem 271 (1996), 9902–9905.
12. Becher, B., Antel, J.P., Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18 (1996), 1–10.
13. Beers, D.R., Henkel, J.S., Xiao, Q., Zhao, W., Wang, J., Yen, A.A., et al. Wild-type microglia extend survival in PU.1 knockout mice with familiar amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 103 (2006), 16021–16026.
14. Benito, C., Núnez, E., Tolón, R.M., Carrier, E.J., Rábano, A., Hillard, C.J., et al. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaques-associated glia in Alzheimer's disease brains. J Neurosci 23 (2003), 11136–11141.
15. Benito, C., Romero, J.P., Tolón, R.M., Clemente, D., Hillard, C.J., Docagne, F., et al. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27 (2007), 2396–2402.
16. Berdyshev, E.V., Schmid, P.C., Krebsbach, R.J., Hillard, C.J., Huang, C., Chen, N., et al. Cannabinoid-receptor-independent cell signaling by N-acylethanolamines. Biochem J 360 (2001), 67–75.
17. Bernardo, A., Ajmone-Cat, M.A., Gasparini, L., Ogini, E., Minghetti, L., Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen. J Neurochem 92 (2005), 895–903.
18. Bertrand, J.Y., Jalil, A., Klaine, M., Jung, S., Cumano, A., Godin, I., Three pathways to mature macrophages in the early mouse yolk sac. Blood 106 (2005), 3004–3011.
19. Bessis, A., Bechade, C., Bernard, D., Roumier, A., Microglial control of neuronal death and synaptic properties. Glia 55 (2007), 233–238.
20. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M.G., Ligresti, A., et al. Cloning the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163 (2003), 436–438.
21. Blalock, E.M., Geddes, J.W., Chen, K.C., Porter, N.M., Markesbery, W.R., Landfield, P.W., Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101 (2004), 2173–2178.
22. Blankman, J.L., Simon, G.M., Cravatt, B.F., A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14 (2007), 1347–1356.
23. Block, M.L., Zecca, L., Hong, J.S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8 (2007), 57–69.
24. Börner, C., Bedini, A., Höllt, V., Kraus, J., Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes. Mol Pharmacol 73 (2008), 1013–1019.
25. Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D., et al. Cannabinoid receptor expression in human leukocytes. Eur J Biochem 214 (1993), 173–180.
26. Brusco, A., Tagliaferro, P., Saez, T., Onaivi, E.S., Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 62 (2008), 944–949.
27. Bruttger, J., Karram, K., Wörtge, S., Regen, T., Marini, F., Hoppmann, N., et al. Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system. Immunity 43:1 (2015), 92–106.
28. Burnette-Curley, D., Cabral, G.A., Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol. Proc Soc Exp Biol Med 210 (1995), 64–76.
29. Cabral, G.A., Staab, A., Effects on the immune system. Handb Exp Pharmacol 168 (2005), 385–423.
30. Carlisle, S.J., Marciano-Cabral, F., Staab, A., Ludwick, C., Cabral, G.A., Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol 2 (2002), 69–82.
31. Carrier, E.J., Kearn, C.S., Barkmeier, A.J., Breese, N.M., Yang, W., Nithipatikom, K., et al. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol 65 (2004), 999–1007.
32. Centonze, D., Finazzi-Agrò, A., Bernardi, G., Maccarrone, M., The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci 28 (2007), 180–187.
33. Cherry, J.D., Olschowka, J.O., O'Banion, M.K., Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11 (2014), 10–15.
34. Chiurchiù, V., Lanuti, M., Catanzaro, G., Fezza, F., Rapino, C., Maccarrone, M., Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. Atherosclerosis 233 (2014), 55–63.
35. Chorr, V., Le Charpentier, T., Lebon, S., Oré, M.V., Celador, I.L., Josserand, J., et al. Characterization of phenotype markers and neurotoxic potential of polarised primary-microglia in vitro. Brain Behav Immun 32 (2013), 70–85.
36. Colangelo, V., Schurr, J., Ball, M.J., Pelaez, R.P., Bazan, N.G., Lukiw, W.J., Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70 (2002), 462–473.
37. Colton, C.A., Heteogeneity of microglial activation in the innate immune response in the brain. J NeuroImmune Pharmacol 4 (2009), 399–418.
38. Colton, C.A., Mott, R.T., Sharpe, H., Xu, Q., Van Nostrand, W.E., Vitek, M.P., Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation, 3, 2006, 27.
39. Conde, J.R., Streit, W.J., Microglia in the aging brain. J Neuropathol Exp Neurol 65 (2006), 199–203.
40. Correa, F., Hernangómez, M., Mestre, L., Loría, F., Spagnolo, A., Docagne, F., et al. Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB. Glia 58 (2010), 135–147.
41. Cravatt, B.F., Lichtman, A.H., Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 7 (2003), 469–475.
42. Croxford, J.L., Yamamura, T., Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?. J Neuroimmunol 166 (2005), 3–18.
43. Daneman, R., The blood–brain barrier in health and disease. Ann Neurol 72 (2012), 648–672.
44. Dauer, W., Przedborski, S., Parkinson's disease: mechanisms and models. Neuron 39 (2003), 889–909.
45. Davalos, D., Grutzendler, J., Yang, G., Kim, J.V., Zuo, Y., Jung, S., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8 (2005), 752–758.
46. David, S., Kroner, A., Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12 (2011), 388–399.
47. Del Río-Hortega, P., Penfield, W., (eds.) Cytology and Cellular Pathology of the Nervous System, 1932, Hoeber, 481–534.
48. Desestret, V., Riou, A., Chauveau, F., Cho, T.-H., Devillard, E., Marinescu, M., et al. In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLoS One, 8, 2013, e67063.
49. Di Marzo, V., Endocannabinoid signaling in the brain: biosynthetic mechanisms in the timelight. Nat Neurosci 14 (2011), 9–15.
50. Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J.A., et al. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264 (1999), 258–267.
51. DiCarlo, G., Wilcock, D., Henderson, D., Gordon, M., Morgan, D., Intrahippoccampal LPS injections reduce Abeta load in APP + PS1 transgenic mice. Neurobiol Aging 22 (2001), 1007–1012.
52. Dirikoc, S., Priola, S.A., Marella, M., Zsürger, N., Chabry, J., Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity. J Neurosci 27 (2007), 9537–9544.
53. Durafourt, B.A., Moore, C.S., Zammit, D.A., Johnson, T.A., Zaquia, E., Guiot, M.C., et al. Comparison of polarization properties of human microglia and blood-derived macrophages. Glia 60 (2012), 717–727.
54. Ehrhart, J., Obregon, D., Mori, T., Hou, H., Sun, N., Bai, Y., et al. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation, 2, 2005, 29.
55. Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P.M., Wolf, S., et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49 (2006), 67–79.
56. Elmore, M.R.P., Najafi, A.R., Koike, M.A., Dagher, N.N., Spangenberg, E.E., Rice, M.A., et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82 (2014), 380–397.
57. Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M., Leon, A., Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia 41 (2003), 161–168.
58. Fedoroff, S., Zhai, R., Novak, J.P., Microglia and astroglia have a common progenitor cell. J Neurosci Res 50 (1997), 477–486.
59. Feliú, A., Moreno-Martet, M., Mecha, M., Carrillo-Salinas, F.J., de Lago, E., Fernández-Ruiz, J., Guaza, C., A Sativex(®)-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. Br J Pharmacol 172:14 (2015), 3579–3595.
60. Fenn, A.M., Hall, J.C., Gensel, J.C., Popovich, P.G., Godbout, J.P., IL-4 signaling drives a unique arginase +/IL-1β + microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4Rα after traumatic spinal cord injury. J Neurosci 34:26 (2014), 8904–8917.
61. Fenn, A.M., Henry, C.J., Huang, Y., Dugan, A., Godbout, J.P., Lypopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice. Brain Behav Immun 26 (2012), 766–777.
62. Fernández-López, D., Martínez-Orgado, J., Nuñez, E., Romero, J., Lorenzo, P., Moro, M.A., et al. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic–ischemic brain damage in newborn rats. Pediatr Res 60 (2006), 169–173.
63. Fitzpatrick, J.K., Downer, E., Toll-like receptor signaling as a cannabinoid target in multiple sclerosis. Neuropharmacology, 2016, 10.1016/j.neuropharm.2016.04.009.
64. Fontainhas, A.M., Wang, M., Liang, K.J., Chen, S., Mettu, P., Damani, M., et al. Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PLoS One, 6, 2011, e15973.
65. Fowler, C.J., Anandamide uptake explained?. Trends Pharmacol Sci 33 (2012), 181–185.
66. Frank-Cannon, T.C., Alto, L.T., McAlpine, F.E., Tansey, M.G., Does neuroinflammation fan the flame in neurodegenerative diseases?. Mol Neurodegener, 4, 2009, 47.
67. Freund, T.F., Katona, I., Piomelli, D., Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83 (2003), 1017–1066.
68. Fujita, S., Kitamura, T., Origin of brain macrophages and the nature of the so-called microglia. Acta Neuropathol Suppl 6 (1975), 291–296.
69. Furlan, R., Poliani, P.L., Galbiati, F., Bergami, A., Grimaldi, L.M., Comi, G., et al. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Hum Gene Ther 9 (1998), 2605–2617.
70. Galea, I., Palin, K., Newman, T.A., Van Rooijen, N., Perry, V.H., Boche, D., Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia 49 (2005), 375–384.
71. Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232 (1995), 54–61.
72. Gao, H.M., Kotzbauer, P.T., Uryu, K., Leight, S., Trojanowski, J.Q., Lee, V.M., Neuroinflammation and oxidation/nitration of alphasynuclein linked to dopaminergic neurodegeneration. J Neurosci 28 (2008), 7687–7698.
73. García-Ovejero, D., Arévalo-Martín, A., Navarro-Galve, B., Pinteaux, E., Molina-Holgado, E., Molina-Holgado, F., Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling. Biochem Soc Trans 41 (2013), 1577–1582.
74. Gerhauser, I., Hansmann, F., Puff, C., Kumnok, J., Schaudien, D., Wewetzer, K., et al. Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro. J Neuroimmunol 252 (2012), 49–55.
75. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330 (2010), 841–845.
76. Ginhoux, F., Lim, S., Hoeffel, G., Low, D., Huber, T., Origin and differentiation of microglia. Front Cell Neurosci, 7, 2013, 45.
77. Gokoh, M., Kishimoto, S., Oka, S., Sugiura, T., 2-arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells. Biol Pharm Bull 30 (2007), 1199–1205.
78. Gomez Perdiguero, E., Schulz, C., Geissmann, F., Development and homeostasis of “resident” myeloid cells: the case of the microglia. Glia 61 (2013), 112–120.
79. Grabner, G.F., Eichmann, T.O., Wagner, B., Gao, Y., Farzi, A., Taschler, U., et al. Deletion of monoglyceride lipase in astrocytes attenuates lipopolysaccharide-induced neuroinflammation. J Biol Chem 291:2 (2016), 913–923.
80. Graeber, M.B., Changing face of microglia. Science 330 (2010), 783–788.
81. Guo, Y., Zhang, H., Yang, J., Liu, S., Bing, L., Gao, J., Hao, A., Granulocyte colony-stimulating factor improves alternative activation of microglia under microenvironment of spinal cord injury. Neuroscience 238 (2013), 1–10.
82. Hains, B.C., Waxman, S.G., Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26:16 (2006), 4308–4317.
83. Hao, C., Richardson, A., Fedoroff, S., Macrophage-like cells originate from neuroepithelium in culture: characterization and properties of the macrophage-like cells. Int J Dev Neurosci 9 (1991), 1–14.
84. Henkel, J.S., Beers, D.R., Zhao, W., Appel, S.H., Microglia in ALS: the good, the bad and the resting. J NeuroImmune Pharmacol 4:4 (2009), 389–398.
85. Heppner, F.L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11 (2005), 146–152.
86. Herber, D.L., Roth, L.M., Wilson, D., Wilson, N., Mason, J.E., Morgan, D., et al. Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. Exp Neurol 190 (2004), 245–253.
87. Herbomel, P., Thisse, B., Tihisse, C., Zebrafish early macrophages colonize cephalic mesenchyme and developing brain, retina and epidermis through a M-CSF receptor-dependent invasive process. Dev Biol 238 (2001), 274–288.
88. Herder, V., Iskandar, C.D., Kegler, K., Hansmann, F., Elmarabet, S.A., Khan, M.A., et al. Dynamic changes of microglia/macrophage M1 and M2 polarization in Theiler's murine encephalomyelitis. Brain Pathol 25 (2015), 712–723.
89. Hernangómez, M., Carrillo-Salinas, F.J., Mecha, M., Correa, F., Mestre, L., Loría, F., et al. Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200–CD200R interaction involve the cannabinoid system. Curr Pharm Des 20 (2014), 4707–4722.
90. Heumann, R., Moratalla, R., Herrero, M.T., Chakrabarty, K., Drucker-Colin, R., García-Montes, J.R., et al. Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions. J Neurochem 130 (2014), 472–489.
91. Hillard, C.J., Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Mediat 61 (2000), 3–18.
92. Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., et al. Classification of cannabinoid receptors. XXVII International Union of Pharmacology. Pharmacol Rev 54 (2002), 161–202.
93. Hsieh, C.L., Kim, C.C., Ryba, B.E., Niemi, E.C., Bando, J.K., Locksley, R.M., et al. Traumatic brain injury induces macrophage subsets in the brain. Eur J Immunol 43 (2013), 2010–2022.
94. Hu, X., Li, P., Guo, Y., Wang, H., Leak, R.K., Chen, S., et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43 (2012), 3063–3070.
95. Hughes, V., Microglia: the constant gardeners. Nature 485 (2012), 570–572.
96. Hume, D.A., Perry, V.H., Gordon, S., Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 97 (1983), 253–257.
97. Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., Hashizume, Y., Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol 106 (2003), 518–526.
98. Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., Izzo, A.A., Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem 89:1 (2004), 134–141.
99. Jiang, M.H., Chung, E., Chi, G.F., Ahn, W., Lim, J.E., Hong, H.S., et al. Substance P induces M2-type macrophages after spinal cord injury. Neuroreport 23 (2012), 786–792.
100. Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-González, I., Torres, M., Sánchez-Varo, R., et al. Inflammatory response in the hippocampus of Ps1m146l/app 751sl mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. Adv Exp Med Biol 28 (2008), 11650–11661.
101. Karran, E., Mercken, M., De Strooper, B., The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapies. Nat Rev Drug Discov 10 (2011), 698–712.
102. Kawahara, K., Suenobu, M., Yoshida, A., Koga, K., Hyodo, A., Ohtsuka, H., et al. Intracerebral injection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. Neuroscience 207 (2012), 243–260.
103. Kettenmann, H., Hanisch, U.K., Noda, M., Verkhratsky, A., Physiology of microglia. Physiol Rev 91 (2011), 461–553.
104. Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E.G., et al. Microglia emerge from erythromyeloid precursors via PU.1 and Irf8 dependent pathways. Nat Neurosci 16 (2013), 273–280.
105. Kigerl, K.A., Gensel, J.C., Ankeny, D.P., Alexander, J.K., Donnelly, D.J., Popovich, P.G., Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29 (2009), 13435–13444.
106. Kim, S.R., Kim, S.U., Oh, U., Jin, B.K., Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2 +-mediated mitochondrial damage and cytochrome c release. J Immunol 177 (2006), 4622–4629.
107. Kim, K., Moore, D.H., Makriyannis, A., Abood, M.E., AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse of amyotrophic lateral sclerosis. Eur J Pharmacol 542 (2006), 100–105.
108. Kim, H.J., Ifergan, I., Antel, J.P., Seguin, R., Duddy, M., Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J Immunol 172 (2004), 7144–7153.
109. Kim, Y.S., Kim, S.S., Cho, J.J., Choi, D.H., Hwang, O., Shin, D.H., et al. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J Neurosci 25 (2005), 3701–3711.
110. Kitamura, T., Miyake, T., Fujita, S., Genesis of resting microglia in the gray matter of mouse hippocampus. J Comp Neurol 226 (1984), 421–433.
111. Kiyota, T., Okuyama, S., Swan, R.J., Jacobsen, M.T., Gendelman, H.E., Ikezu, T., CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP + PS1 bigenic mice. FASEB J 24 (2010), 3093–3102.
112. Klegeris, A., Bissonnette, C.J., McGeer, P.L., Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol 139 (2003), 775–786.
113. Koenigsknecht-Talboo, J., Landreth, G.E., Microglial phagocytosis induced by fibrilar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 25 (2005), 8240–8249.
114. Koh, W.S., Yang, K.H., Kaminski, N.E., Cyclic AMP is an essential factor in immune responses. Biochem Biophys Res Commun 206 (1995), 703–709.
115. Kumar, A., Stoica, B.A., Sabirzhanov, B., Burns, M.P., Faden, A.I., Loane, D.J., Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging 34 (2013), 1397–1411.
116. Kumaravelu, P., Hook, L., Morrison, A.M., Ure, J., Zhao, S., Zuyev, S., et al. Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (HSC/RUs): role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver. Development 129 (2002), 4891–4899.
117. Langston, J.W., Forno, L.S., Tetrud, J., Reeves, A.G., Kaplan, J.A., Karluk, D., Evidence of active nerve cell degeneration in the substantia nigra of human years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine exposure. Ann Neurol 46 (1999), 598–605.
118. Lassmann, H., Schmied, M., Vass, K., Hickey, W.F., Bone marrow derived elements and resident microglia in brain inflammation. Glia 7 (1993), 19–24.
119. Lawson, L.J., Perry, V.H., Dri, P., Gordon, S., Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39 (1990), 151–170.
120. Lee, E.J., Woo, M.S., Moon, P.G., Baek, M.C., Choi, I.Y., Kim, W.K., et al. Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J Immunol 185 (2010), 615–623 (73).
121. Liberatore, G.T., Jackson-Lewis, V., Vukosavic, S., Mandir, A.S., Vila, M., McAuliffe, W.G., et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 52 (1999), 1403–1409.
122. Lisboa, S.F., Gomes, F.V., Guimaraes, F.S., Campos, A.C., Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders. Front Neurol, 7, 2016, 5.
123. Litchman, A.H., Blankman, J.L., Cravatt, B.J., Endocannabinoid overload. Mol Pharmacol 78 (2010), 993–995.
124. Liu, J., Batkai, S., Pacher, P., Harvey-White, J., Wagner, J.A., Cravatt, B.F., et al. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activated factor. J Biol Chem 278 (2003), 45034–45039.
125. Liu, J., Wang, L., Harvey-White, J., Osei-Hyiaman, D., Razdan, R., Gong, Q., et al. Novel biosynthetic pathway for anandamide. Proc Natl Acad Sci U S A 103 (2006), 13345–13350.
126. Lourbopoulos, A., Grigoriadis, N., Lagoudaki, R., Touloumi, O., Polyzoidou, E., Mavromatis, I., et al. Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis. Brain Res 1390 (2011), 126–141.
127. Lu, C., Liu, Y., Sun, B., Sun, Y., Hou, B., Zhang, Y., et al. Intrathecal injection of JWH-015 attenuates bone cancer pain via time-dependent modification of pro-inflammatory cytokines expression and astrocyte activity in spinal cord. Inflammation 38:5 (2015), 1880–1890.
128. Lyman, W.D., Sonett, J.R., Brosnan, C.F., Elkin, R., Bornstein, M.B., Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol 23 (1989), 73–81.
129. Ma, L., Jia, J., Liu, X., Bai, F., Wang, Q., Xiong, L., Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling. Biochem Biophys Res Commun 458:1 (2015), 92–97.
130. Mackie, K., Hille, B., Cannabinoids inhibit N-type calcium channels in neuroblastoma–glioma cells. Proc Natl Acad Sci U S A 89 (1992), 3825–3829.
131. Mackie, K., Lai, Y., Westenbroek, R., Mitchell, R., Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Qtype calcium currents in AtT20 cells transfected with rat brain cannabinoid receptors. J Neurosci 15 (1995), 6552–6561.
132. Malek, N., Popiolek-Barczyk, K., Mika, J., Przewlocka, B., Starowicz, K., Anandamide, acting via CB2 receptors, alleviates LPS-induced neuroinflammation in rat primary microglial cultures. Neural Plast, 2015, 2015, 130639.
133. Mantovani, A., Biswas, S.K., Galdiero, M.R., Sica, A., Locati, M., Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229 (2013), 176–185.
134. Marcellino, D., Carriba, P., Filip, M., Borgkvist, A., Frankowska, M., Bellido, I., et al. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 54 (2008), 815–823.
135. Maresz, K., Carrier, E.J., Ponomarev, E.D., Hillard, C.J., Dittel, B.N., Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95 (2005), 437–445.
136. Maroof, N., Pardon, M.C., Kendall, D.A., Endocannabinoid signalling in Alzheimer's disease. Biochem Soc Trans 41 (2013), 1583–1587.
137. Marrs, W.R., Blankman, J.L., Horne, E.A., Thomazeau, A., Lin, Y.H., Coy, J., et al. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci 13 (2010), 951–957.
138. Marsicano, G., Goodenough, S., Monory, K., CB1 cannabinoid receptors and on demand defense against excitotoxicity. Science 302 (2003), 84–88.
139. Martín, A.B., Fernandez-Espejo, E., Ferrer, B., Gorriti, M.A., Bilbao, A., Navarro, M., et al. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 33 (2008), 1667–1679.
140. Martín-Couce, L., Martín-Fontecha, M., Palomares, O., Mestre, L., Cordomí, A., Hernangomez, M., et al. Chemical probes for the recognition of cannabinoid receptors in native systems. Angew Chem Int Ed 51 (2012), 6896–6899.
141. Martinez, F.O., Gordon, S., The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000 Prime Rep, 6, 2014, 13.
142. Martinez, F.O., Helming, L., Gordon, S., Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27 (2009), 451–483.
143. Martin-Moreno, A.M., Brera, M., Spuch, C., Carro, E., Garcia-Garcia, L., Delgado, M., et al. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation, 9, 2012, 8.
144. Martin-Moreno, A.M., Reigada, D., Ramírez, B.G., Mechoulam, R., Innamorato, N., Cuadrado, A., et al. Cannabidiol and other cannabinoids reduce microglial activation in vitro an in vivo: relevance to Alzheimer's disease. Mol Pharmacol 79:6 (2011), 964–973.
145. Massi, P., Vaccani, A., Parolaro, D., Cannabinoids, immune system and cytokine network. Curr Pharm Des 12 (2006), 3135–3146.
146. Matias, I., Pochard, P., Orlando, P., Salzet, M., Pestel, J., Di Marzo, V., Presence and regulation of the endocannabinoid system in human dendritic cells. Eur J Biochem 269 (2002), 3771–3778.
147. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., Bonner, T.I., Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990), 561–564.
148. McAlpine, F.E., Lee, J.K., Harms, A.S., Ruhn, K.A., Blurton-Jones, M., Hong, J., et al. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis 34 (2009), 163–177.
149. McGeer, P.L., Itagaki, S., Boyes, B.E., McGeer, E.G., Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988), 1285–1291.
150. McHugh, D., Hu, S.S., Rimmerman, N., Juknat, A., Vogel, Z., Walker, J.M., et al. N-arachidonoyl glycine potently drives directed BV-2 microglial migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci, 11, 2010, 44.
151. McKercher, S.R., Torbett, B.E., Anderson, K.L., Henkel, G.W., Vestal, D.J., Baribault, H., et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15 (1996), 5647–5658.
152. Mecha, M., Feliú, A., Carrillo-Salinas, F.J., Rueda-Zubiaurre, A., Ortega-Gutiérrez, S., De Sola, R.G., et al. Endocannabinoids drive the acquisition of an alternative phenotype in microglia. Brain Behav Immun 49 (2015), 233–245.
153. Mechoulam, R., The pharmacohistory of Cannabis sativa. Mechoulam, R., (eds.) Cannabis as therapeutic agent, 1986, CRC Press, Boca Raton, FL, 1–19.
154. Mechoulam, R., Parker, L.A., The endocannabinoid system and the brain. Annu Rev Psychol 64 (2013), 21–47.
155. Mestre, L., Docagne, F., Correa, F., Loría, F., Hernangómez, M., Borrell, J., et al. A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Mol Cell Neurosci 40 (2009), 258–266.
156. Mestre, L., Iñigo, P.M., Mecha, M., Correa, F.G., Hernangómez-Herrero, M., Loría, F., et al. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors. J Neuroinflammation, 8, 2011, 102.
157. Michell-Robinson, M.A., Touil, H., Healy, L.M., Owen, D.R., Durafourt, B.A., Bar-Or, A., et al. Roles of microglia in brain development, tissue maintenance and repair. Brain 138 (2015), 1138–1159.
158. Michelucci, A., Heurtaux, T., Grandbarbe, L., Morga, E., Heuschling, P., Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillary amyloid-β. J Neuroimmunol 210 (2009), 3–12.
159. Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.K., et al. Microglia in the adult brain arise from Ly-6ChiCCR2 + monocytes only under defined host conditions. Nat Neurosci 10 (2007), 1544–1553.
160. Miller, L.K., Devi, L.A., The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev 63 (2011), 461–470.
161. Miller, A.M., Stella, N., CB2 receptor-mediated migration of immune cells: it can go either way. Br J Pharmacol 153 (2008), 299–308.
162. Miron, V.E., Boyd, A., Zhao, J.W., Yuen, T.J., Ruckh, J.M., Shadrach, J.L., et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16 (2013), 1211–1218.
163. Molina-Holgado, E., Vela, J.M., Arévalo-Martín, A., Almazán, G., Molina-Holgado, F., Borrell, J., et al. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3-kinase/Akt signaling. J Neurosci 22 (2002), 9742–9753.
164. Moravan, M.J., Olschowka, J., Williams, J.P., O'Banion, M.K., Brain radiation injury leads to a dose- and time-dependent recruitment of peripheral myeloid cells that depends on CCR2 signaling. J Neuroinflammation, 13(1), 2016, 30.
165. More, S.V., Choi, D.K., Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection. Mol Neurodegener, 8(10), 2015, 17.
166. Moreno-Martet, M., Feliú, A., Espejo-Porras, F., Mecha, M., Carrillo-Salinas, F.J., Fernández-Ruiz, J., et al. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors. Mult Scler Relat Disord 4:6 (2015), 505–511.
167. Morganti, J.M., Jopson, T.D., Liu, S., Gupta, N., Rosi, S., Cranial irradiation alters the brain's microenvironment and permits CCR2 + macrophage infiltration. PLoS One, 9(4), 2014, e93650.
168. Munro, S., Thomas, K.L., Abu-Shaar, M., Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993), 61–65.
169. Murabe, Y., Sano, Y., Morphological studies on neuroglia. VII. Distribution of “brain macrophages” in brains of neonatal and adult rats, as determined by means of immunohistochemistry. Cell Tissue Res 229 (1983), 85–95.
170. Murataeva, N., Straiker, A., Mackie, K., Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. Br J Pharmacol 171 (2014), 1379–1391.
171. Murikinati, S., Jüttler, E., Keinert, T., Ridder, D.A., Muhammad, S., Waibler, Z., et al. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J 24 (2010), 788–798.
172. Naito, M., Takahashi, K., Nishikawa, S., Development, differentiation, and maturation of macrophages in the fetal mouse liver. J Leukoc Biol 48 (1990), 27–37.
173. Nakajima, H., Uchida, K., Guerrero, A.R., Watanabe, S., Sugita, D., Takeura, N., et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma 29 (2012), 1614–1625.
174. Nathan, C., Calingasan, N., Nezezon, J., Ding, A., Lucia, M.S., La Perle, K., et al. Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J Exp Med 202 (2005), 1163–1169.
175. Nimmerjahn, A., Kirchhoff, F., Helmchen, F., Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 (2005), 1314–1318.
176. Nomura, D.K., Morrison, B.E., Blankman, J.L., Long, J.Z., Kinsey, S.G., Marcondes, M.C., et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334:6057 (2011), 809–813.
177. Norden, D.M., Godbout, J.P., Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 39:1 (2013), 19–34.
178. Orkin, S.H., Zon, L.I., Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132 (2008), 631–644.
179. Ortega-Gutiérrez, S., Molina-Holgado, E., Arévalo-Martín, A., Correa, F., Viso, A., López-Rodríguez, M.L., et al. Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis. FASEB J 19 (2005), 1338–1340.
180. O'Sullivan, S.E., Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152 (2007), 576–582.
181. O'Sullivan, S.E., Kendall, D.A., Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory diseases. Immunobiology 215 (2010), 611–626.
182. Pacher, P., Bátkai, S., Kunos, G., The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 (2006), 389–462.
183. Paolicelli, R.C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333 (2011), 1456–1458.
184. Perez-de Puig, I., Miro, F., Salas-Perdomo, A., Bonfill-Teixidor, E., Ferrer-Ferrer, M., Márquez-Kisionusky, L., et al. IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion. J Cereb Blood Flow Metab 33 (2013), 1955–1966.
185. Perez-Rial, S., Garcia-Gutierrez, M.S., Molina, J.A., Perez-Nievas, B.G., Ledent, C., Leiva, C., et al. Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors. Neurobiol Aging 32 (2011), 631–645.
186. Perry, V.H., Hume, D.A., Gordon, S., Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15 (1985), 313–326.
187. Perry, V.H., Nicoll, J.A., Holmes, C., Microglia in neurodegenerative disease. Nat Rev Neurol 6 (2010), 193–201.
188. Pertwee, R.G., Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond Ser B Biol Sci 367:1607 (2012), 3353–3363.
189. Pertwee, R.G., Howlett, A.C., Abood, M.E., Alexander, S.P., Di Marzo, V., Elphick, M.R., et al. International unión of basic and clinical pharmacology LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62 (2010), 588–631.
190. Pietr, M., Kozela, E., Levy, R., Rimmerman, N., Lin, Y.H., Stella, N., et al. Differential changes in GPR55 during microglial cell activation. FEBS Lett 583 (2009), 2071–2076.
191. Piro, J.R., Benjamin, D.I., Duerr, J.M., Pi, Y., Gonzales, C., Wood, K.M., et al. A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease. Cell Rep 1:6 (2012), 617–623.
192. Polazzi, E., Monti, B., Microglia and neuroprotection: from in vitro studies to therapeutic implications. Prog Neurobiol 92 (2010), 293–315.
193. Ponomarev, E.D., Maresz, K., Tan, Y., Dittel, B.N., CNS-derived interleukin-4 is essential for the regulation of autoinmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27 (2007), 10714–10721.
194. Popovich, P.G., Longbrake, E.E., Can the immune system be harnessed to repair the CNS?. Nat Rev Neurosci 9 (2008), 481–493.
195. Priller, J., Flugel, A., Wehner, T., Boentert, M., Haas, C.A., Prinz, M., et al. Tareting gene-modified hematopoietic cells to the central nervous system; use of green fluorescent protein uncovers microglial engraftment. Nat Med 7 (2001), 1356–1361.
196. Prinz, M., Priller, J., Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Immunol 15 (2014), 300–312.
197. Prinz, M., Priller, J., Sisodia, S.S., Ransohoff, R.M., Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 14 (2011), 1227–1235.
198. Puffenbarger, R.A., Boothe, A.C., Cabral, G.A., Cannabinoids inhibit LPS-inducible cytokine mRNA exression in rat microglial cells. Glia 29 (2000), 58–69.
199. Pullen, L.C., Miller, S.D., Dal Canto, M.C., Van der Meide, P.H., Kim, B.S., Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. J Neuroimmunol 55 (1994), 143–152.
200. Racz, I., Nadal, X., Alferink, J., Banos, J.E., Rehnelt, J., Martín, M., et al. Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain. J Neurosci 28 (2008), 12136–12145.
201. Raes, G., Van den Bergh, R., De Baetselier, P., Ghassabeh, G.H., Scotton, C., Locati, M., et al. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J Immunol 174 (2005), 6561–6562.
202. Ramirez, B.G., Blazquez, C., Gomez del Pulgar, T., Guzman, M., de Ceballos, M., Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25 (2005), 1904–1913.
203. Ransohoff, R.M., Cardona, A.E., The myeloid cells of the central nervous system parenchyma. Nature 468 (2010), 253–262.
204. Reynolds, A.D., Kadiu, I., Garg, S.K., Glanzer, J.G., Nordgren, T., Ciborowski, P., et al. Nitrated alpha-synuclein and microglial neuroregulatory activities. J NeuroImmune Pharmacol, 3(59–74), 2008, 75.
205. Ribeiro, A., Ferraz-de-Paula, V., Pinheiro, M.L., Vitoretti, L.B., Mariano-Souza, D.P., Quinteiro-Filho, W.M., et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Eur J Pharmacol 678 (2012), 78–85.
206. Rivest, S., Regulation of the innate immune responses in the brain. Nat Rev Immunol 9 (2009), 429–439.
207. Rockwell, C.E., Snider, N.T., Thompson, J.T., Vanden Heuvel, J.P., Kaminski, N.E., Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. Mol Pharmacol 70 (2006), 101–111.
208. Rojanathammanee, L., Murphy, E.J., Combs, C.K., Expression of mutant alpha-synuclein modulates microglial phenotype in vitro. J Neuroinflammation, 8, 2011, 44.
209. Rom, S., Persidsky, Y., Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J NeuroImmune Pharmacol 8 (2013), 608–620.
210. Sacerdote, P., Martucci, C., Vaccani, A., Bariselli, F., Panerai, A.E., Colombo, A., et al. The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. J Neuroimmunol 159 (2005), 97–105.
211. Saijo, K., Glass, C.K., Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11 (2011), 775–787.
212. Salzet, M., Breton, C., Bisogno, T., Di Marzo, V., Comparative biology of the endocannabinoid system: possible role in the immune response. Eur J Biochem 267 (2000), 4917–4927.
213. Sanchez-Guajardo, V., Barnum, C.J., Tansey, M.G., Romero-Ramos, M., Neuroimmunological processes in Parkinson's disease and their relation to alpha-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neurol 5 (2013), 113–139.
214. Schmid, C.D., Melchior, B., Masek, K., Puntambekar, S.S., Danielson, P., Lo, D., et al. Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J Neurochem 109 (2009), 117–125.
215. Schulz, C., Gomez Perdiguero, E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdof, K., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336 (2012), 86–90.
216. Shaw, M.K., Lorens, J.B., Dhawan, A., DalCanto, R., Tse, H.Y., Tran, A.B., et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 185 (1997), 1711–1741.
217. Shechter, R., Miller, O., Yovel, G., Rosenzweig, N., London, A., Ruckh, J., et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote choroid plexus. Immunity 38 (2013), 555–569.
218. Shiratsuchi, A., Watanabe, I., Yoshida, H., Nakanishi, Y., Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis. Immunol Cell Biol 86 (2008), 179–184.
219. Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. Clin Invest 122 (2012), 787–795.
220. Sieger, D., Moritz, C., Ziegenhals, T., Prykhozhij, S., Peri, F., Long range Ca2 + waves transmit brain-damage signals to microglia. Dev Cell 22 (2012), 1138–1148.
221. Sierra, A., Encinas, J.M., Deudero, J.J., Chancey, J.H., Enikolopov, G., Overstreet-Wadiche, L.S., et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7 (2010), 483–495.
222. Simon, G.M., Cravatt, B.F., Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta hydrolase 4 in this pathway. J Biol Chem 281 (2006), 26465–26472.
223. Sinha, D., Bonner, T.I., Bhat, N.R., Matsuda, L.A., Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies. J Neuroimmunol 82 (1998), 13–21.
224. Spittau, B., Wullkopf, L., Zhou, X., Rilka, J., Pfeifer, D., Krieglstein, K., Endogenous transforming growth factor-beta promotes quiescence of primary microglia in vitro. Glia 61 (2013), 287–300.
225. Stefano, G.B., Liu, Y., Goligorsky, M.S., Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 271 (1996), 19238–19242.
226. Stein, M., Keshav, S., Harris, N., Gordon, S., Interleukin 4 potently enhances murine macrophage mannose receptor activity: a maker of alternative immunologic macrophage activation. J Exp Med 176 (1992), 287–292.
227. Stella, N., Endocannabiniod signaling in microglial cells. Neuropharmacology 56 (2009), 244–253.
228. Stella, N., Schweitzer, P., Piomelli, D., A second endogenous cannabinoid that modulates long-term potentiation. Nature 338 (1997), 773–778.
229. Stence, N., Waite, M., Dailey, M.E., Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 33 (2001), 256–266.
230. Streit, W.J., Mrak, R.E., Griffin, W.S.T., Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation, 1, 2004, 14.
231. Suárez-Pinilla, P., López-Gil, J., Crespo-Facorro, B., Immune system: a possible nexus between cannabinoids and psychosis. Brain Behav Immun 40 (2014), 269–282.
232. Tanasescu, R., Constantinescu, C.S., Cannabinoids and the immune system: an overview. Immunobiology 215 (2010), 588–597.
233. Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., et al. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 65:3 (2010), 320–327.
234. Tansey, M.G., McCoy, M.K., Frank-Cannon, T.C., Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 208 (2007), 1–25.
235. Thaler, J.P., Yi, C.X., Schur, E.A., Guyenet, S.J., Hwang, B.H., Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 122:1 (2012), 153–162.
236. Thawer, S.G., Mawhinney, L., Chadwick, K., de Chickera, S.N., Weaver, L.C., Brown, A., et al. Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-egfp-ki mouse model. J Neuroimmunol 261 (2013), 7–20.
237. Theodore, S., Cao, S., McLean, P., Standaert, D.G., Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol 67 (2008), 1149–1158.
238. Tolón, R.M., Núñez, E., Pazos, M.R., Benito, C., Castillo, A.I., Martínez-Orgado, J.A., et al. The activation of cannabinoid CB2 rereptors stimulates in situ and in vitro beta-amyloid removal by human macrophages. Brain Res 1283 (2009), 148–154.
239. Tsou, K., Brown, S., Sañudo-Peña, M.C., Mackie, K., Walker, J.M., Inmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998), 393–411.
240. Tuma, R.F., Steffens, S., Targeting the endocannabinoid system to limit myocardial and cerebral ischemic and reperfusion injury. Curr Pharm Biotechnol 13 (2012), 46–58.
241. Varin, A., Gordon, S., Alternative activation of macrophages: immune function and cellular biology. Immunobiology 214 (2009), 630–641.
242. Varvel, N.H., Grathwohl, S.A., Baumann, F., Liebig, C., Bosch, A., et al. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proc Natl Acad Sci U S A 109 (2012), 18150–18155.
243. Viader, A., Blankman, J.L., Zhong, P., Liu, X., Schlosburg, J.E., Joslyn, C.M., et al. Metabolic interplay between astrocytes and neurons regulates endocannabinoid action. Cell Rep 12:5 (2015), 798–808.
244. Viader, A., Ogasawara, D., Joslyn, C.M., Sánchez-Alavez, M., Mori, S., Nguyen, W., et al. A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation. Elife, 18, 2016, 5.
245. Vogel, D.Y., Vereyken, E.J., Glim, J.E., Heijnen, P.D., Moeton, M., van der Valk, P., et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation state. J Neuroinflammation, 10, 2013, 35.
246. Von Bernhardi, R., Eugenín-von Bernhardi, L., Eugenín, J., Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci, 7, 2015, 124.
247. Voss, E.V., Škuljec, J., Gudi, V., Skripuletz, T., Pul, R., Trebst, C., et al. Characterization of microglia during de- and remyelination: can they create a repair promoting environment?. Neurobiol Dis 45 (2012), 519–528.
248. Waksman, Y., Olson, J.M., Carlisle, S.J., Cabral, G.Y., The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther 288 (1999), 1357–1366.
249. Walker, F.R., Nilsson, M., Jones, K., Acute and chronic stress-induced disturbances of microglial plasticity, phenotype and function. Curr Drug Targets 14:11 (2013), 1262–1276.
250. Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., et al. Non-psychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23 (2003), 1398–1405.
251. Walton, N.M., Sutter, B.M., Laywell, E.D., Levkoff, L.H., Kearns, S.M., Marshall, G.P. II, et al. Microglia instruct subventricular zone neurogenesis. Glia 54 (2006), 815–825.
252. Wen, J., Ribeiro, R., Tanaka, M., Zhang, Y., Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis. Neuropharmacology 99 (2015), 196–209.
253. Wilcock, D.M., Lewis, M.R., Van Nostrand, W.E., Davis, J., Previti, M.L., Gharkholonarehe, N., et al. Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase. J Neurosci 28 (2008), 1537–1545.
254. Wirguin, I., Mechoulam, R., Breuer, A., Schezen, E., Weidenfeld, J., Brenner, T., Suppression of experimental autoimmune encephalomyelitis by cannabinoids. Immunopharmacology 28 (1994), 209–214.
255. Witting, A., Chen, L., Cudaback, E., Straiker, A., Walter, L., Rickman, B., et al. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc Natl Acad Sci U S A 103 (2006), 6362–6367.
256. Witting, A., Walter, L., Wacker, J., Moller, T., Stella, N., P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci U S A 101 (2004), 3214–3219.
257. Wu, D.C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., et al. NAPDH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6,-tetrahydropropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 100 (2003), 6145–6150.
258. Xiong, X., Barreto, G.E., Xu, L., Ouyang, Y.B., Xie, X., Giffard, R.G., Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke 42 (2011), 2026–2032.
259. Yang, J., Jiang, Z., Fitzgerald, D.C., Ma, C., Yu, S., Li, H., et al. Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J Clin Invest 119 (2009), 3678–3691.
260. Yi, J.H., Park, S.W., Brooks, N., Lang, B.T., Vemuganti, R., PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res 1244 (2008), 164–172.
261. Yuan, M., Kiertscher, S.M., Cheng, Q., Zoumalan, R., Tashkin, D.P., Roth, M.D., Delta 9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol 133 (2002), 124–131.
262. Zecca, L., Zucca, F.A., Wilms, H., Sulzer, D., Neuromelanin of the susbstantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci 26 (2003), 570–580.
263. Zhang, M., Adler, M.W., Abood, M.E., Ganea, D., Jallo, T., Tuma, R.F., CB2 receptor activation decreases microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc Res 78 (2009), 86–94.
264. Zhang, W., Dallas, S., Zhang, D., Guo, J.P., Pang, H., Wilson, B., et al. Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alphasynuclein. Glia 55 (2007), 1178–1188 (74).
265. Zhang, J., Hoffert, C., Vu, K., Roblewski, T., Ahmad, S., O'Donnell, D., Induction of CB2 receptors expression in the rat spinal cord of neuropathic but not inflammatory chronic pain model. Eur J Neurosci 17 (2003), 2750–2754.
266. Zhang, M., Martin, B.R., Adler, M.W., Razdan, R.K., Jallo, J.I., Tuma, R.F., Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab 27 (2007), 1387–1396.
267. Zhang, W., Wang, T., Pei, Z., Miller, D.S., Wu, X., Block, M.L., et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 19 (2005), 533–542 (72).
268. Ziebell, J.M., Rowe, R.K., Muccigrosso, M.M., Reddaway, J.T., Adelson, P.D., Godbout, J.P., et al. Aging with a traumatic brain injury: could behavioral morbidities and endocrine symptoms be influenced by microglial priming?. Brain Behav Immun, 2016, 10.1016/j.bbi.2016.03.008.